2073 - Impact of in-house Candida auris polymerase chain reaction (PCR) screening on admission on the incidence rates of surveillance and clinical cultures with C. auris and associated cost-savings

Presenting Author(s)

• 

  Rossana M. Rosa, MD (she/her/hers)

  Physician
  Jackson Health System
  Fredericton, NB, Canada

  Slides

Co-Author(s)

• AJ

  Adriana Jimenez, MPH, MLS(ASCP), CIC

  Infection Control Manager
  Jackson Health System, Infection Prevention and Control Department
  Miami, FL, United States
• DA

  David Andrews, MD

  University of Miami
  Miami, Florida, United States
• HD

  Huy Dinh, MT, MBA

  Sr. Clinical Laboratory Manager
  Jackson Health System
  Miami, Florida, United States
• KP

  Katiuska Parra, MPH, BSMT

  Lab Supervisor
  Jackson Health System
  Miami, Florida, United States
• OM

  Octavio Martinez, Ph.D., ABMM

  Director, Clinical Microbiology Laboratory
  Jackson Health System/University of Miami
  Miami, FL, United States
• 

  Lilian M. Abbo, MD, MBA (she/her/hers)

  Professor of Infectious Diseases; Associate Chief Medical Officer in Infectious Diseases
  University of Miami Miller School of Medicine, Miami Transplant Institute and Jackson Health System
  Miami, FL, United States